← Browse by Condition
Medical Condition
circulating tumor cell
Total Trials
3
Recruiting Now
3
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for circulating tumor cell sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Top Sponsors
1 trial
1 trial
1 trial
NCT04782557
Recruiting
EUS Guided HVA and PVA for Circulating Tumor DNA in Patients
Enrollment
60 pts
Location
Hong Kong
Sponsor
Chinese University of Hong Kon...
NCT06755762
Recruiting
Using a 3D Culture Model for Circulating Tumor Cells Combined With Molecular Bioassays in Patients With HNSCC Cancer
Enrollment
88 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT05346536
Recruiting
Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)
Enrollment
63 pts
Location
France
Sponsor
University Hospital, Montpelli...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology